Deutsche Bank’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $971K | Buy |
83,847
+75,082
| +857% | +$869K | ﹤0.01% | 2097 |
|
2025
Q1 | $76.5K | Sell |
8,765
-1,425
| -14% | -$12.4K | ﹤0.01% | 3251 |
|
2024
Q4 | $146K | Buy |
10,190
+2,657
| +35% | +$38.2K | ﹤0.01% | 3155 |
|
2024
Q3 | $170K | Buy |
7,533
+479
| +7% | +$10.8K | ﹤0.01% | 2959 |
|
2024
Q2 | $137K | Buy |
7,054
+451
| +7% | +$8.77K | ﹤0.01% | 2970 |
|
2024
Q1 | $248K | Buy |
6,603
+1,259
| +24% | +$47.3K | ﹤0.01% | 2682 |
|
2023
Q4 | $299K | Sell |
5,344
-6,171
| -54% | -$345K | ﹤0.01% | 2608 |
|
2023
Q3 | $475K | Buy |
11,515
+25
| +0.2% | +$1.03K | ﹤0.01% | 2183 |
|
2023
Q2 | $642K | Buy |
11,490
+987
| +9% | +$55.1K | ﹤0.01% | 2227 |
|
2023
Q1 | $586K | Sell |
10,503
-6,991
| -40% | -$390K | ﹤0.01% | 2399 |
|
2022
Q4 | $637K | Buy |
17,494
+9,657
| +123% | +$352K | ﹤0.01% | 2312 |
|
2022
Q3 | $223K | Sell |
7,837
-3,306
| -30% | -$94.1K | ﹤0.01% | 2869 |
|
2022
Q2 | $505K | Sell |
11,143
-98,325
| -90% | -$4.46M | ﹤0.01% | 2586 |
|
2022
Q1 | $8.33M | Sell |
109,468
-3,659
| -3% | -$278K | ﹤0.01% | 1170 |
|
2021
Q4 | $16.9M | Sell |
113,127
-26,701
| -19% | -$3.98M | 0.01% | 908 |
|
2021
Q3 | $20.4M | Buy |
139,828
+11,417
| +9% | +$1.66M | 0.01% | 895 |
|
2021
Q2 | $25.1M | Buy |
128,411
+44,065
| +52% | +$8.63M | 0.01% | 828 |
|
2021
Q1 | $15.3M | Buy |
84,346
+16,774
| +25% | +$3.04M | 0.01% | 997 |
|
2020
Q4 | $9.57M | Buy |
67,572
+65,446
| +3,078% | +$9.27M | 0.01% | 1057 |
|
2020
Q3 | $265K | Sell |
2,126
-175,606
| -99% | -$21.9M | ﹤0.01% | 3021 |
|
2020
Q2 | $15.9M | Buy |
177,732
+171,779
| +2,886% | +$15.3M | 0.01% | 782 |
|
2020
Q1 | $371K | Hold |
5,953
| – | – | ﹤0.01% | 2619 |
|
2019
Q4 | $453K | Hold |
5,953
| – | – | ﹤0.01% | 2753 |
|
2019
Q3 | $300K | Buy |
+5,953
| New | +$300K | ﹤0.01% | 2925 |
|